Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4…

Overview of attention for article published in Lancet Oncology, September 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 8 news outlets
twitter: 13 X users
patent: 5 patents

wikipedia: 3 Wikipedia pages
guideline: 6 clinical guideline sources

Readers on

mendeley: 274 Mendeley

So far, Altmetric has seen 8 news stories from 8 outlets.

Breast Cancer Index Assay Prognostic for Distant Recurrence in Estrogen Receptor–Positive, Node-Negative Breast Cancer

The ASCO Post, 13 Nov 2013

In a study reported in The Lancet Oncology, Dennis C. Sgroi, MD, of Massachusetts General Hospital, and colleagues compared the…

Gene-expression-based biomarker predicts long-term risk of breast cancer recurrence

Medical News Today, 15 Sep 2013

A comparison of three methods of predicting the risk of recurrence in women treated for estrogen-receptor (ER)-positive breast…

Gene-expression-based biomarker predicts long-term risk of breast cancer recurrence

e! Science News, 12 Sep 2013

A comparison of three methods of predicting the risk of recurrence in women treated for estrogen-receptor (ER)-positive breast…

Researchers Focus on Likelihood of Breast Cancer Recurrence

WebMD News, 12 Sep 2013

Seven tumor-specific genes appear to yield accurate prognosis, study says

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 4 additional news stories.